The results showed that IL‐17A‐positive staining was significantly increased in WHO III‐IV glioma tissues compared to that in WHO I‐II glioma tissues and Adjacent tissues (**P < 0.01) (Figure 1A and B). Here, IL17A is linked to central nervous system cancer.